Expression profile analysis of prognostic long non-coding RNA in adult acute myeloid leukemia by weighted gene co-expression network analysis (WGCNA)
Cunte Chen, Peipei Wang, Wenjian Mo, Yuping Zhang, Wei Zhou, Tingfen Deng, Ming Zhou, Xiaowei Chen, Shunqing Wang, Caixia Wang · Journal of Cancer · 2019
Not cached yet. This record was fetched live for this request and is stored after the lookup. Reopening the page should serve the cached copy.
Journal of Cancer · Ivyspring International Publisher · article · 2019
Abstract
Background: Long non-coding RNAs (lncRNAs), which are over 200 nt in length, have a key role in tumorigenesis and disease progression.To explore the role of prognostic lncRNAs in adult acute myeloid leukemia (AML), the expression profiles of lncRNAs and mRNAs in AML were analyzed.Methods: The RNAseq data of 167 adult AML patients and the corresponding clinical information were downloaded from The Cancer Genome Atlas (TCGA), which is a publicly available database.The RPKM values of the RNAseq data were subjected to weighted gene co-expression network analysis (WGCNA) in modularization.Results: We identified survival specific lncRNAs and mRNAs, which were divided into modules by coexpression analysis.The lncRNAs were mainly annotated into "Fc gamma R-mediated phagocytosis".The hub lncRNA and co-expressed mRNAs were further selected for analysis of risk stratification.LncRNA-LOC646762 may contribute to AML through the "endocytosis" signaling pathway.Finally, the expression levels of LOC646762 and co-expressed CCND3, CBR1, C10orf54, CD97 and BLOC1S1 in the adult AML patients and healthy volunteers were validated by qRT-PCR, and then their roles in prognosis and risk stratification were identified.Conclusions: Prognostic lncRNA-LOC646762, which may contribute to AML through the "endocytosis" signaling pathway, may act as a biomarker for predicting the survival of adult AML patients, as well as for risk stratification.
Open the resolved locator · 10.7150/jca.31234
Metadata licence: OpenAlex metadata (CC0)